Microneedle Drug Delivery CRO/CDMO
Hours: 8:30 AM–5:30 PMSales: +86 10 8928 7035Business: bd@casmn.com

Application-led evaluation for microneedle product development

Microneedle Delivery Applications

Explore microneedle delivery considerations for peptides, proteins, biologics, vaccines, metabolic programs, dermatology, pain management and long-acting delivery.
01

Peptides, Proteins and Biologics

Microneedle feasibility depends on target dose, molecular stability, formulation compatibility, delivery efficiency and the intended product pathway.

02

Vaccines and Intradermal Delivery

Intradermal delivery programs require application-specific assessment of antigen stability, loading strategy, delivery performance and manufacturing controls.

03

Metabolic and GLP-1-Related Research

Programs involving peptide payloads require careful review of dose capacity, stability, release profile and the practical patch design.

04

Dermatology and Pain Management

Localized delivery concepts are assessed against target tissue, intended use, active ingredient properties and regulatory classification.

05

Long-Acting Delivery

Sustained-release approaches may involve layered structures, microparticles or implantable microneedle designs and require integrated formulation and process evaluation.

Request an Application Assessment

Send your target product, payload, development stage and cooperation scope to our business development team.

Start a Project